Company Overview
Snapshot
Founded in June 2023 by Uri Blumenthal and Amit Ashkenazi, Surgical KIS operates with 1–10 employees. The company has secured funding across one round. In January 2024, Surgical KIS received Seed funding from Youdim Pharmaceuticals.
Business overview
Surgical KIS is a Health Tech & Life Sciences company developing an innovative system for surgical sutures. Its core product, the SLEEK suture, aims to enhance the efficiency, speed, and precision of attaching artificial heart valves to heart tissues, offering a user-friendly, cost-effective, and metal-free alternative to conventional manual methods. The company operates within the Medical Devices and Assistive Devices sectors, serving the Healthcare and Providers markets.
Log in to access full profile ›Company Intelligence Q&A
- When was Surgical KIS founded?
- Surgical KIS was founded in June 2023 by Uri Blumenthal and Amit Ashkenazi.
- What is the primary product developed by Surgical KIS?
- Surgical KIS is developing the SLEEK suture system, designed to attach artificial heart valves to heart tissues more efficiently, quickly, and precisely than traditional methods.
- What is the employee count for Surgical KIS?
- Surgical KIS currently has 1–10 employees.
- Which investor participated in Surgical KIS's Seed funding round?
- In January 2024, Surgical KIS received Seed funding from Youdim Pharmaceuticals.
- What problem does the SLEEK suture system aim to solve?
- The SLEEK suture system aims to provide a more efficient, precise, and cost-effective solution for attaching artificial heart valves, addressing the limitations of conventional manual surgical methods.